Matrixx Initiatives' Zicam Cold Products May Damage Smell


The Food and Drug Administration warned that use of Matrixx Initiatives' (Nasdaq: MTXX) Zicam Cold Remedy products may permanently damage a person's sense of smell sending the stock price plummeting $13.46 to close at $5.78.

About this Entry

This page contains a single entry by published on June 16, 2009 3:30 PM.

Capstone Turbine Widens Losses was the previous entry in this blog.

Earnings Drop For A-Power is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12